TcLand Expression TcLand Teams with Radboud Univ. on Biomarkers for RA Drug Response TcLand Expression Receives $1.7M to Validate Companion Dx for Rheumatoid Arthritis The funding will be used primarily to set up a European multi-center clinical trial for the validation of a molecular test to predict non-response to anti-TNF treatment, in particular Remicade. People in the News: Dec 23, 2010 (rev. 1) Premium Celera names Merriweather as SVP and CFO; TcLand Expression appoints Payne as CBO. Pairings: Dec 22, 2010 Premium Peter Payne TcLand Licenses Patents to Develop RA Companion Dx The French firm also said it has received $564,000 in funding for the project. Apr 15, 2009 Pairings: Apr 15, 2009 Premium Apr 10, 2009 People in the News: Apr 10, 2009 Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.